| Next 10 |
Ad
SBFM News and Press Sunshine Biopharma Inc.
News | Sunshine Biopharma Inc. (NASDAQ:SBFM)
-
2025-06-11 08:45:08 ET More on Sunshine Biopharma Seeking Alpha’s Quant Rating on Sunshine Biopharma Historical earnings data for Sunshine Biopharma Financial information for Sunshine Biopharma Read the full article on Seeking Alpha For further...
-
FORT LAUDERDALE, FL / ACCESS Newswire / June 11, 2025 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals today announced that its wholly owned Canad...
-
FORT LAUDERDALE, FL / ACCESS Newswire / May 15, 2025 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals today announced that it has filed its 2025 f...
-
FORT LAUDERDALE, F / ACCESS Newswire / May 6, 2025 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals today announced that its wholly owned Canadian...
-
2025-04-21 08:58:28 ET DENVER, Colo., Apr 21, 2025 ( 247marketnews.com ) – Sunshine Biopharma (NASDAQ:SBFM) stated that its wholly owned Canadian subsidiary, Nora Pharma, launched Everolimus in Canada’s generic prescription drug market. Everolimus, a generic equivalent of ...
-
FORT LAUDERDALE, FL / ACCESS Newswire / April 21, 2025 / Sunshine Biopharma Inc. (NASDAQ:SBFM), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals today announced that its wholly owned Canadian subsidiary,...
- SBFM - BioMedNewsBreaks - Sunshine Biopharma Inc. (NASDAQ: SBFM) Secures $2.46M in Registered Direct
2025-04-03 15:21:45 ET Sunshine Biopharma (NASDAQ: SBFM) , a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals, has closed its previously announced registered direct offering with institutional inves...
-
FORT LAUDERDALE, FL / ACCESS Newswire / April 3, 2025 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals, today announced the closing of the previou...
-
FORT LAUDERDALE, FL / ACCESS Newswire / April 2, 2025 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals, today announced that it has entered into d...
-
2025-04-02 11:50:00 ET April 2, 2025 (Investorideas.com Newswire) Investorideas.com ( www.investorideas.com ), a go-to platform for big investing ideas for stock traders, including biotech stocks reports on trading and news for Sunshine Biopharma Inc. ( NASDAQ:SBFM ) a pharmaceu...
Stock Information
Get SBFM Alerts
News, Short Squeeze, Breakout and More Instantly...
Sunshine Biopharma Inc. Company Name:
SBFM Stock Symbol:
NASDAQ Market:
0.11% G/L:
$1.4766 Last:
22,331 Volume:
$1.44 Open:
$1.475 Close:
Sunshine Biopharma Inc. Website:
Ad
-
FORT LAUDERDALE, FL / ACCESS Newswire / June 11, 2025 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals today announced that its wholly owned Canad...
-
FORT LAUDERDALE, FL / ACCESS Newswire / May 15, 2025 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals today announced that it has filed its 2025 f...
-
FORT LAUDERDALE, F / ACCESS Newswire / May 6, 2025 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals today announced that its wholly owned Canadian...